|
JPS60136511A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
高尿酸血症治療剤
|
|
JPS63501289A
(ja)
|
1985-09-27 |
1988-05-19 |
ザ リ−ジエンツ オブ ザ ユニバ−シテイ オブ カリフオルニア |
リポソ−ム経皮薬剤供給系
|
|
JPS6295134A
(ja)
|
1985-10-21 |
1987-05-01 |
Nippon Saafuakutanto Kogyo Kk |
リポソ−ムの製造法
|
|
US5015483A
(en)
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
|
US5498607A
(en)
|
1990-07-30 |
1996-03-12 |
University Of Miami |
Treatment for hypercholesterolemia
|
|
JP3765579B2
(ja)
|
1990-08-24 |
2006-04-12 |
イーデーエーアー アーゲー |
作用物質投与用超微小滴状調剤
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
US5498420A
(en)
|
1991-04-12 |
1996-03-12 |
Merz & Co. Gmbh & Co. |
Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
|
|
WO1994001089A1
(de)
|
1992-07-08 |
1994-01-20 |
Dianorm-Geräte G. Maierhofer |
Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels
|
|
FR2714382B1
(fr)
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
FR2767691B1
(fr)
|
1997-08-27 |
2000-02-18 |
Oreal |
Utilisation d'une dispersion a base de vehicules lipidiques comme composition anti-inflammatoire
|
|
CA2311128C
(en)
*
|
1997-11-19 |
2008-01-29 |
Schering Aktiengesellschaft |
Composition with azelaic acid
|
|
US6165997A
(en)
|
1997-11-20 |
2000-12-26 |
Statens Serum Institut |
Phospholipids having antimicrobial activity with or without the presence of antimicrobials
|
|
AU9740498A
(en)
|
1998-09-01 |
2000-03-21 |
Idea Ag |
Electrically controlled transport of charged penetrants across barriers
|
|
TR200101790T2
(tr)
|
1998-12-23 |
2001-10-22 |
Idea Ag. |
Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül
|
|
EP1031346B1
(en)
|
1999-01-27 |
2002-05-02 |
Idea Ag |
Noninvasive vaccination through the skin
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
AU5409699A
(en)
|
1999-07-05 |
2001-01-22 |
Idea Ag |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6248728B1
(en)
|
2000-03-10 |
2001-06-19 |
Kansas State University Research Foundation |
Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol
|
|
US6191121B1
(en)
*
|
2000-04-06 |
2001-02-20 |
Nicholas V. Perricone |
Treatment of skin damage using polyenylphosphatidylcholine
|
|
EP1272161B1
(en)
|
2000-04-12 |
2008-01-02 |
Liplasome Pharma A/S |
Lipid-based drug delivery systems against parasitic infections
|
|
TWI281407B
(en)
|
2000-09-18 |
2007-05-21 |
Vasogen Ireland Ltd |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment
|
|
US20030064948A1
(en)
|
2001-02-08 |
2003-04-03 |
Alfred Fahr |
Invasomes for therapy of disorders, their preparation and use
|
|
HUP0600294A2
(en)
|
2001-05-31 |
2007-02-28 |
Pharmacia Corp |
Skin-permeable selective cyclooxygenase-2 inhibitor composition
|
|
CA2451245A1
(en)
|
2001-06-25 |
2003-01-03 |
Depuy International Limited |
Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
|
|
CA2368656A1
(en)
|
2002-01-21 |
2003-07-21 |
Vasogen Ireland Limited |
Receptor-ligand pairing for anti-inflammatory response
|
|
ES2411656T3
(es)
|
2002-03-13 |
2013-07-08 |
Thomas SKÖLD |
Sistemas de administración a base de agua
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7473432B2
(en)
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
|
JP2004131432A
(ja)
|
2002-10-11 |
2004-04-30 |
Kumamoto Technology & Industry Foundation |
悪性腫瘍抑制剤
|
|
EP1815847A3
(en)
|
2002-10-11 |
2008-11-05 |
Idea Ag |
Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
WO2004098524A2
(en)
|
2003-05-02 |
2004-11-18 |
Aronex Pharmaceuticals, Inc. |
Lipid platinum complexes and methods of use thereof
|
|
EP1658086A2
(en)
|
2003-07-21 |
2006-05-24 |
Vasogen Ireland Limited |
Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
|
|
JP2005179313A
(ja)
|
2003-12-24 |
2005-07-07 |
Shu Uemura:Kk |
皮膚化粧料用基剤の製造方法および皮膚化粧料
|
|
US7476432B2
(en)
|
2004-05-28 |
2009-01-13 |
Tecton Products |
Phosphorescent pultrusion
|
|
US20080095722A1
(en)
|
2004-11-12 |
2008-04-24 |
Idea Ag |
Extended Surface Aggregates in the Treatment of Skin Conditions
|
|
WO2006086992A2
(en)
|
2005-02-18 |
2006-08-24 |
Liplasome Pharma A/S |
Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
|
|
US20070042008A1
(en)
|
2005-08-18 |
2007-02-22 |
Bodybio, Inc. |
Compositions containing phosphatidylcholine and essential fatty acids
|
|
UA89545C2
(uk)
|
2005-08-29 |
2010-02-10 |
Сепсикюр Л.Л.К. |
Спосіб лікування чи попередження станів, викликаних грампозитивними бактеріями
|
|
ES2511772T3
(es)
|
2005-12-20 |
2014-10-23 |
Cenestra, Llc |
Formulaciones de ácidos grasos omega-3
|
|
JP5009547B2
(ja)
|
2006-03-31 |
2012-08-22 |
株式会社コーセー |
顔料とリポソームを含む化粧料
|
|
US7544375B1
(en)
|
2006-06-12 |
2009-06-09 |
Swiss Skin Repair, Inc. |
Composition
|
|
CN101541308B
(zh)
|
2006-09-28 |
2012-02-01 |
哈达斯特医疗研究服务和开发有限公司 |
甘油磷脂用于关节润滑的用途
|
|
JP4732307B2
(ja)
|
2006-11-20 |
2011-07-27 |
株式会社アンズコーポレーション |
ナノエマルション及びそれを配合した化粧料
|
|
US20100130611A1
(en)
|
2006-12-20 |
2010-05-27 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
ITVR20080006A1
(it)
|
2008-01-23 |
2009-07-24 |
David Ceretta |
Apparato per la realizzazione di elementi d'impasto
|
|
ES2335636B1
(es)
|
2008-02-29 |
2011-05-11 |
Lipotec, S.A. |
Composicion cosmetica o dermofarmaceutica de micelas mixtas.
|
|
JP2009256331A
(ja)
|
2008-03-25 |
2009-11-05 |
Nagase Chemtex Corp |
高尿酸血症、又は痛風の予防、改善、又は治療剤
|
|
US20100105139A1
(en)
|
2008-10-27 |
2010-04-29 |
Remco Alexander Spanjaard |
Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
|
|
EP2393480A1
(en)
|
2009-02-05 |
2011-12-14 |
Targeted Delivery Technologies Limited |
Methods of reducing the proliferation and viability of microbial agents
|
|
MY170121A
(en)
|
2009-06-03 |
2019-07-05 |
Ulrich Vierl |
Formulations for the treatment of deep tissue pain
|
|
GB2486371A
(en)
*
|
2009-08-21 |
2012-06-13 |
Targeted Delivery Technologies Ltd |
Vesicular formulations
|
|
EP2382994A1
(en)
|
2010-04-26 |
2011-11-02 |
Maurizio Victor Cattaneo |
Ligand targeted nanocapsules for the delivery of RNAi and other agents
|
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
US20120045405A1
(en)
|
2010-08-18 |
2012-02-23 |
Gilman Miles E |
Under eye cream
|
|
GB201206486D0
(en)
|
2012-04-12 |
2012-05-30 |
Sequessome Technology Holdings Ltd |
Vesicular formulations and uses thereof
|
|
GB201208384D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
|
GB201208409D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, kits and uses
|
|
CN114949237A
(zh)
|
2013-07-31 |
2022-08-30 |
斯昆申技术控股有限责任公司 |
囊泡
|